MYC and glioblastoma: Recently, the results of our studies suggested that HDAC8i could overcome TMZ resistance in glioblastoma multiforme (GBM) by downregulating the β-catenin/c-Myc/SOX2 pathway and upregulating p53-mediated MGMT inhibition [8].